What Is Your Compounding Pharmacy Actually Worth? A 2026 Valuation Guide
By SlimionRX Business Team, Pharmacy Revenue Specialists — Published February 28, 2026
2026 guide to compounding pharmacy valuation — EBITDA multiples, SDE analysis, what increases your multiple, prescriber concentration risk, compliance record impact, and exit readiness scoring.
Frequently Asked Questions
- Why Most Pharmacy Owners Don't Know Their Number
- The question "what is my pharmacy worth?" is one that most owners don't ask until they're planning to sell — and by then, it's often too late to optimize the answer. Pharmacy valuation is both a financial calculation and an operational assessment. Understanding how buyers evaluate pharmacies helps you build the right kind of business from day one — not just the most profitable business in the short term.
- What Drives Your Multiple Down
- - Over-reliance on a single compound category (e.g., 70% of revenue from GLP-1 compounding at a time when regulatory changes could restrict it) - Unresolved compliance issues or inspection findings - High owner dependency (pharmacy operations cannot function without the owner's direct daily involvement)